CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 3,374.9	$ 3,408.0	$ 2,936.9
Operating costs and expenses:
Cost of sales	2,035.1	2,120.3	1,930.7
Selling, general and administrative	797.5	775.4	698.1
Loss on divestiture of asbestos-related assets and liabilities	162.4	0.0	0.0
Restructuring charges (gains), net	10.4	(16.9)	32.3
Acquisition-related and integration charges	0.0	0.0	12.9
Operating profit	369.5	529.2	262.9
Other income (expense):
Interest income	3.4	1.4	2.0
Interest expense	(52.2)	(46.9)	(55.3)
Gain on sale of business	232.5	0.0	0.0
Miscellaneous income, net	9.8	19.1	14.9
Total other income (expense)	193.5	(26.4)	(38.4)
Net income before allocation to noncontrolling interests	563.0	502.8	224.5
Provision for income taxes	161.9	67.4	43.4
Net income before allocation to noncontrolling interests	401.1	435.4	181.1
Less: Noncontrolling interest in subsidiaries’ earnings	0.0	0.0	0.1
Net income attributable to common shareholders	$ 401.1	$ 435.4	$ 181.0
Earnings per share:
Earnings per basic share (in dollars per share)	$ 7.11	$ 7.46	$ 3.10
Earnings per diluted share (in dollars per share)	$ 7.01	$ 7.36	$ 3.08
Average shares outstanding:
Weighted average basic shares outstanding (in shares)	56.4	58.4	58.3
Weighted average diluted shares outstanding (in shares)	57.2	59.2	58.8